Evidence map›Paper›PMID 38689365›Full record

SynthesisSystematic reviews2024

Safety and efficacy of intravenous thrombolysis before mechanical thrombectomy in patients with atrial fibrillation.

Qiangji Bao, Xiaodong Huang, Xinting Wu, Hao Huang, Xiaoqiang Zhang, Mingfei Yang

Open access · goldAbstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Systematic reviews, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Heart Failure and Stroke: A Narrative Review.Journal of clinical medicine · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Qiangji Bao *Department of Neurosurgery, Guang'an People's Hospital, Guang'an, Sichuan, China.
Xiaodong Huang *Department of Neurosurgery, Taihe Hospital Affiliated Hospital of Hubei University of Medicine, Shiyan, Hubei, China.
Xinting WuDepartment of Anesthesia, Guang'an People's Hospital, Guang'an, Sichuan, 638000, China.
Hao Huang *Department of Neurosurgery, Guang'an People's Hospital, Guang'an, Sichuan, China.
Xiaoqiang ZhangDepartment of Neurosurgery, Guang'an People's Hospital, Guang'an, Sichuan, China. zhang2202492@163.com.
Mingfei YangDepartment of Neurosurgery, Qinghai Provincial People's Hospital, Xining, Qinghai, 810007, China. iloveyoucmu@163.com.
Guang’anmen Hospital · CNQinghai Provincial Peoples Hospital · CNTaihe Hospital · CN

Funding

Guang 'an Science and Technology Bureau 2023zdxjh03Kunlun Talents of Qinghai Province•High-end Innovation and Entrepreneurship Talent Project-Cultivate leading talents. not applicate
6 · The paper itself

Abstract

backgroundIntravenous thrombolysis (IVT) before endovascular thrombectomy (EVT) is the standard treatment for patients with acute ischemic stroke caused by large vessel occlusion (AIS-LVO). However, the efficacy and safety of IVT before EVT in AIS-LVO patients with atrial fibrillation (AF) remains controversial. Thus, this study aims to assess the benefit of IVT plus EVT and direct EVT alone in AIS-LVO patients with AF.

methodRelevant studies that evaluated the outcomes of IVT plus EVT versus direct EVT alone in AIS-LVO patients with AF were systematically searched in PubMed, Embase, and Cochrane Library from inception to August 10, 2023. The outcomes included successful reperfusion (score of 2b to 3 for thrombolysis in cerebral infarction), symptomatic intracerebral hemorrhage (sICH), good clinical outcome (modified Rankin scale score ≤ 2) at 3 months, and 3-month mortality.

resultEight eligible observational studies involving 6998 (3827 in the IVT plus EVT group and 3171 in the direct EVT group) patients with AIS-LVO complicated by AF were included. Compared with direct EVT, IVT plus EVT resulted in better 3-month clinical outcomes (odds ratio [OR] 1.27, 95% confidence interval [CI] 1.05-1.54) and lower 3-month mortality (OR 0.78, 95% CI 0.68-0.88). However, the incidence of sICH (OR 1.26, 95% CI 0.91-1.75) and the rate of successful reperfusion (OR 0.98, 95% CI 0.83-1.17) were not significantly different between treatment modalities.

conclusionIVT plus EVT leads to better functional outcomes and lower mortality in AIS-LVO patients with AF. Withholding IVT plus EVT from patients with AF alone may not be justified.

Indexed as

Atrial FibrillationIschemic StrokeThrombectomyThrombolytic TherapyAdministration, IntravenousCombined Modality TherapyEndovascular ProceduresFibrinolytic AgentsHumansTreatment OutcomeFibrinolytic AgentsAtrial fibrillationIntravenous thrombolysisIschemic strokeLarge vessel occlusionMechanical thrombectomy

Identifiers

PMID38689365
PMCPMC11061942
OpenAlexW4396511070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.